Friday, August 8, 2025

This PSU’s earnings may peak in FY25 and decline thereafter, Kotak Institutional Equities warns

Date:

Brokerage firm Kotak Institutional Equities believes that the earnings of state-run miner NMDC Ltd. is likely to peak in the current financial year and decline thereafter.As a result, the brokerage has a “sell” recommendation on NMDC with a price target of ₹55, which implies a further 15% downside from current levels. The stock is already down 31% from its recent peak of ₹95.

Kotak’s price target on NMDC

is also the lowest on the street for the stock.
The brokerage said that declining iron ore prices on increasing market surplus for seaborne iron ore and increasing supply pressure in India with a ramp-up of merchant iron ore mines directly competing with NMDC’s Chhattisgarh mines are some key headwinds for the stock, both locally and globally.NMDC’s future expansion plans are significantly return dilutive and the Karnataka tax bill, if implemented, could sharply impact earnings and is not built into our base case, Kotak wrote in its note.

Karnataka is an important state for NMDC as it contributes to nearly 35% of the overall mix for the company.

Out of the 23 analysts that have coverage on NMDC, 13 of them have a “buy” rating, four have a “hold” rating, while six have a “sell” rating on the stock. Consensus estimates are projecting a potential upside of 14% for the state-run company.

Shares of NMDC are currently trading 1.9% lower at ₹64.68.

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Bonds prices under pressure ahead of ₹25,000 crore auction of government securities

सरकारी बॉन्ड शुक्रवार को शुरुआती कारोबार में डूबा, क्योंकि...

Anup Engineering Q1 results | Revenue surges 20% year-on-year to ₹175 crore

Gujarat-based Anup Engineering, a manufacturer of critical process equipment...

Samir Arora sees modest returns ahead, no quick RBI rate cut likely

Samir Arora, Founder and Fund Manager at Helios Capital,...

Advances in breast cancer treatments bring in a range of benefits for patients – The Hindu

Advances in breast cancer treatments bring in a range...